Aclaris Therapeutics

Arcutis Biotherapeutics

This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.

Avalo Therapeutics

This clinical-stage biotechnology company develops monoclonal antibody therapies for patients with immune-mediated inflammatory diseases such as hidradenitis suppurativa.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.

Alumis

This company develops oral therapies and precision medicines for patients with immune-mediated disorders including plaque psoriasis and systemic lupus erythematosus.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.

Pharmacyclics

This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.

Acelyrin, Inc

This biopharmaceutical company develops protein therapeutics and monoclonal antibodies to treat inflammatory diseases for patients with unmet medical needs.

Arcutis

This company develops and commercialises topical treatments for patients living with chronic immune-mediated dermatological diseases including psoriasis, seborrhoeic dermatitis and atopic dermatitis.